Aveanna Healthcare (NASDAQ:AVAH) Shares Break Below 50 Day Moving Average – Should You Sell?

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)’s stock price crossed below its 50 day moving average during trading on Thursday. The stock has a 50 day moving average of $13.06 and traded as low as $12.15. Aveanna Healthcare shares last traded at $12.24, with a volume of 4,737,247 shares traded.

Key Stories Impacting Aveanna Healthcare

Investors following AVAH have been watching these stories:

• Positive Sentiment: Third-quarter adjusted earnings were $0.23 per share, above the $0.21 analyst consensus and up from $0.15 a year earlier. Revenue of $695.54 million also beat estimates of $679.48 million. Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2026 Guidance
• Positive Sentiment: Aveanna revised its 2026 guidance; its revenue outlook is $2.7 billion, in line with the consensus estimate. Coverage also characterized the update as raised guidance, a potential signal of management confidence. Aveanna Healthcare Q3 2026: EPS Beats, Guidance Raised
• Neutral Sentiment: Management identified hospice as a priority for mergers and acquisitions. Potential deals could support expansion, though their eventual impact will depend on terms and execution. Hospice an M&A Priority for Aveanna

Analyst Ratings Changes

Several research analysts have recently commented on the company. UBS Group lifted their price objective on Aveanna Healthcare from $8.00 to $13.00 and gave the stock a “neutral” rating in a report on Friday, August 14th. Barclays lifted their price target on shares of Aveanna Healthcare from $9.50 to $15.00 and gave the company an “overweight” rating in a research report on Friday, August 28th. Royal Bank Of Canada boosted their price objective on shares of Aveanna Healthcare from $10.00 to $16.00 and gave the stock an “outperform” rating in a report on Monday, August 24th. JPMorgan Chase & Co. boosted their price objective on shares of Aveanna Healthcare from $8.00 to $15.00 and gave the company a “neutral” rating in a report on Monday, September 14th. Finally, Truist Financial raised their target price on Aveanna Healthcare from $11.00 to $15.00 and gave the stock a “hold” rating in a research report on Monday, August 24th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, Aveanna Healthcare has a consensus rating of “Moderate Buy” and an average price target of $14.25.

Aveanna Healthcare Stock Performance

The company has a debt-to-equity ratio of 4.47, a quick ratio of 1.16 and a current ratio of 1.16. The firm has a market capitalization of $2.67 billion, a PE ratio of 9.95, a price-to-earnings-growth ratio of 0.80 and a beta of 2.03. The business’s fifty day simple moving average is $13.06 and its 200-day simple moving average is $9.44.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings results on Thursday, November 12th. The company reported $0.23 EPS for the quarter, topping the consensus estimate of $0.21 by $0.02. The business had revenue of $695.54 million for the quarter, compared to analysts’ expectations of $679.48 million. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. As a group, equities research analysts expect that Aveanna Healthcare Holdings Inc. will post 0.77 EPS for the current year.

Insider Buying and Selling at Aveanna Healthcare

In other news, major shareholder J.H. Whitney Equity Partners V sold 12,496,077 shares of the firm’s stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $11.50, for a total value of $143,704,885.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Rodney D. Windley sold 180,000 shares of the firm’s stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $11.50, for a total value of $2,070,000.00. Following the completion of the sale, the director owned 2,078,017 shares of the company’s stock, valued at approximately $23,897,195.50. This represents a 7.97% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 48,566,081 shares of company stock worth $558,509,932 over the last three months. 5.30% of the stock is owned by company insiders.

Institutional Investors Weigh In On Aveanna Healthcare

Several hedge funds have recently made changes to their positions in AVAH. Diversified Trust Co increased its holdings in Aveanna Healthcare by 3.6% during the third quarter. Diversified Trust Co now owns 30,932 shares of the company’s stock valued at $384,000 after buying an additional 1,077 shares during the period. Farther Finance Advisors LLC boosted its position in Aveanna Healthcare by 217.1% during the 3rd quarter. Farther Finance Advisors LLC now owns 2,978 shares of the company’s stock valued at $37,000 after acquiring an additional 2,039 shares in the last quarter. Sterling Capital Management LLC boosted its position in Aveanna Healthcare by 398.3% during the 3rd quarter. Sterling Capital Management LLC now owns 2,636 shares of the company’s stock valued at $33,000 after acquiring an additional 2,107 shares in the last quarter. EverSource Wealth Advisors LLC increased its holdings in shares of Aveanna Healthcare by 22.1% in the 1st quarter. EverSource Wealth Advisors LLC now owns 17,552 shares of the company’s stock valued at $113,000 after acquiring an additional 3,172 shares during the period. Finally, Nisa Investment Advisors LLC increased its holdings in shares of Aveanna Healthcare by 104.7% in the 3rd quarter. Nisa Investment Advisors LLC now owns 11,181 shares of the company’s stock valued at $139,000 after acquiring an additional 5,720 shares during the period. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc. is a U.S. provider of home-based healthcare services for children and adults with complex medical needs. Its services include private-duty nursing and personal care, home health nursing and therapy, and hospice care, helping patients receive support in their homes and communities. The company also provides medical supplies and related services, including products used for enteral nutrition. Aveanna serves patients and families across multiple states through a network of clinicians, caregivers, and local operations.